Asked by Chanel Monroe on May 15, 2024
Verified
What problem did Codexis originally face when it examined using enzymes in the synthesis of atorvastatin?
A) They were too expensive to produce.
B) There were not enough of them for the commercial process.
C) They were not sufficiently active for this commercial process.
D) They did not work in the lock-and-key mechanism as expected.
Codexis
A company specializing in the development of enzymes and biocatalytic processes for pharmaceutical and biofuel productions.
Commercial Process
A systematic sequence of activities designed to produce a product or service for the marketplace.
- Gain insight into the procedures for maximizing enzyme utility in the creation of pharmaceutical compounds.
Verified Answer
MS
Maher ShaheenMay 19, 2024
Final Answer :
C
Explanation :
Codexis faced the problem that the enzymes were not sufficiently active for the commercial process of synthesizing atorvastatin, necessitating the development or optimization of enzymes to meet the required activity levels for efficient production.
Learning Objectives
- Gain insight into the procedures for maximizing enzyme utility in the creation of pharmaceutical compounds.
Related questions
How Much Faster Is the Reaction Rate in the Second ...
How Was the Synthesis of Atorvastatin Made Drastically Greener ...
How Did Codexis Solve the Problem of Low Reacting Enzymes ...
Pancreatic Amylase Has the Same Action as Salivary Amylase
What Analogy Is Often Used for the Enzyme-Reactant Interaction ...